Jamie Easterling
Family · Winnsboro, SCNPI 1376194399
Payments from drug & device makers
Across 294 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amgen$472
- Dexcom, Inc.$422
- AstraZeneca$399
- Lilly USA, LLC$343
- Pfizer$156
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,668100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 88 | $1,024 |
| Amgen | 30 | $472 |
| Dexcom, Inc. | 14 | $422 |
| AstraZeneca | 24 | $399 |
| Lilly USA, LLC | 23 | $343 |
| Pfizer | 10 | $156 |
| Novartis | 9 | $152 |
| Bayer | 9 | $144 |
| AbbVie | 9 | $137 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $117 |
| Amarin Pharma, Inc. | 7 | $111 |
| Corcept Therapeutics | 5 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Lundbeck LLC | 3 | $73 |
| Merck | 5 | $72 |
| Insulet Corporation | 3 | $67 |
| Optinose US, Inc. | 4 | $66 |
| Daiichi Sankyo Inc. | 4 | $65 |
| Astellas Pharma US Inc | 3 | $58 |
| Exact Sciences | 3 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Eisai Inc. | 2 | $35 |
| Edwards Lifesciences | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Renalytix AI, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Boehringer Ingelheim | 2 | $32 |
| Abbott | 2 | $29 |
| Boston Scientific | 1 | $25 |
| Genentech USA, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| Stryker | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
How this compares
$4,668 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $52,806 |
| EliquisApixaban | 64 | $49,571 |
| MounjaroTirzepatide | 33 | $40,189 |
| FarxigaDapagliflozin Propanediol | 40 | $34,829 |
| TrulicityDulaglutide | 26 | $26,076 |
| JanuviaSitagliptin Phosphate | 30 | $23,525 |
| JardianceEmpagliflozin | 34 | $21,463 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $20,749 |
| LinzessLinaclotide | 28 | $19,044 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 73 | $16,370 |
| MyrbetriqMirabegron | 21 | $14,771 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $14,265 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $9,661 |
| Bydureon BciseExenatide Microspheres | 11 | $9,428 |
| XareltoRivaroxaban | 12 | $6,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $343 | $66,26559 claims |
| Novo NordiskOzempic | $1,024 | $52,80649 claims |
| PfizerEliquis | $156 | $49,57164 claims |
| AstraZenecaFarxiga, Symbicort | $399 | $40,28756 claims |
| MerckJanuvia | $72 | $23,52530 claims |
| Boehringer IngelheimJardiance | $32 | $21,46334 claims |
| AbbVieLinzess | $137 | $19,04428 claims |
| Astellas Pharma US IncMyrbetriq | $58 | $14,77121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Winnsboro
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.